Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Biﬁdobacterium breve + Bifidobacterium longum + Lacticaseibacillus casei + Lacticaseibacillus rhamnosus + Lactobacillus acidophilus (Webber Naturals Probiotic 5 Billion) & Non-alcoholic fatty liver disease (NAFLD)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Clinical data

IRCT201410052394N13
Probiotic supplementation, when combined with lifestyle interventions, has a favorable impact on glycemic parameters and leptin levels compared to lifestyle intervention alone. This suggests potential benefits for managing non-alcoholic fatty liver disease (NAFLD) through dietary supplementation.
Behrouz et al. 2017

…

References (Sources)

Effects of Probiotic and Prebiotic Supplementation on Leptin, Adiponectin, and Glycemic Parameters in Non-alcoholic Fatty Liver Disease: A Randomized Clinical Trial
Behrouz et al. 2017

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!